|
SBK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26263452418607E-13 |
| Normal-vs-Stage2 |
2.944500E-03 |
| Normal-vs-Stage3 |
2.784100E-02 |
| Normal-vs-Stage4 |
2.816400E-01 |
| Stage1-vs-Stage2 |
7.821600E-01 |
| Stage1-vs-Stage3 |
4.112400E-02 |
| Stage1-vs-Stage4 |
2.086600E-01 |
| Stage2-vs-Stage3 |
1.857160E-01 |
| Stage2-vs-Stage4 |
3.864800E-01 |
| Stage3-vs-Stage4 |
9.740800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
2.46609999999814E-05 |
| Normal-vs-Asian |
3.127400E-01 |
| Caucasian-vs-AfricanAmerican |
2.516400E-03 |
| Caucasian-vs-Asian |
3.359900E-02 |
| AfricanAmerican-vs-Asian |
4.583800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.4432899320127E-15 |
| Normal-vs-Female |
3.4353000000209E-07 |
| Male-vs-Female |
3.792400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.198400E-04 |
| Normal-vs-Extreme_Weight |
2.40599995482427E-09 |
| Normal-vs-Obese |
3.70949999994874E-06 |
| Normal-vs-Extreme_Obese |
9.424100E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.691750E-01 |
| Normal_Weight-vs-Obese |
7.923800E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.198410E-01 |
| Extreme_Weight-vs-Obese |
4.681400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.706000E-01 |
| Obese-vs-Extreme_Obese |
8.689400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.613700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.87649895622144E-12 |
| Normal-vs-Age(61-80Yrs) |
7.55340234803725E-11 |
| Normal-vs-Age(81-100Yrs) |
6.123600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.762600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.135000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.318220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.625600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.687980E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.026300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
9.570600E-01 |
| Normal-VS-KIRP CIMP |
3.696300E-03 |
| Normal-VS-Unclassified PRCC |
8.402000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-KIRP CIMP |
7.933200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.188300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.51859999997228E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.259550E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.166400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.379600E-03 |
| Normal-vs-N1 |
8.237700E-03 |
| Normal-vs-N2 |
9.238200E-01 |
| N0-vs-N1 |
3.161200E-01 |
| N0-vs-N2 |
3.770400E-01 |
| N1-vs-N2 |
2.336000E-01 |
|
|
